Dianthus Therapeutics (DNTH) Times Interest Earned (2017 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Times Interest Earned came in at -$0.32 in Q3 2025, up 47.67% year-on-year from -$0.22 in Q3 2024, and up 85.86% quarter-over-quarter from -$2.26 in Q2 2025.
Dianthus Therapeutics (DNTH) Times Interest Earned (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Times Interest Earned history runs 9 years deep, the most recent figure standing at -$0.32 for Q3 2025.
- On a quarterly basis, Times Interest Earned rose 47.67% year-over-year to -$0.32 in Q3 2025; TTM through Sep 2025 was -$1.11, a 34.27% increase from a year earlier, with the FY2024 full-year figure at -$0.56, down 43.74% from the prior year.
- Times Interest Earned improved to -$0.32 in Q3 2025 per DNTH's latest filing, from -$2.26 in the prior quarter.
- Across five years, Times Interest Earned topped out at $106.39 in Q4 2024 and bottomed at -$2355.2 in Q2 2023.
- The 5-year median for Times Interest Earned is -$2.37 (2025), against an average of -$170.86.
- Across the five-year window, Times Interest Earned sank 151425.72% in 2023 and jumped 99.98% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$3.88 in 2021, then jumped by 80.24% to -$0.77 in 2022, then slumped by 164.93% to -$2.03 in 2023, then jumped by 5340.69% to $106.39 in 2024, then sank by 100.3% to -$0.32 in 2025.
- Per Business Quant, the three latest DNTH Times Interest Earned figures stand at -$0.32 (Q3 2025), -$2.26 (Q2 2025), and -$2.37 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -2.26 |
| Mar 31, 2025 | -2.37 |
| Dec 31, 2024 | 106.39 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -0.52 |
| Mar 31, 2024 | -178.44 |
| Sep 30, 2023 | -2.03 |
| Jun 30, 2023 | -2,355.20 |
| Mar 31, 2023 | -451.94 |
| Sep 30, 2022 | -0.77 |
| Jun 30, 2022 | -1.55 |
| Mar 31, 2022 | -3.10 |
| Dec 31, 2021 | -3.88 |
| Sep 30, 2021 | -2.86 |
| Jun 30, 2021 | -2.48 |
| Mar 31, 2021 | -2.63 |
| Dec 31, 2020 | -0.26 |
| Sep 30, 2020 | -2.88 |
| Jun 30, 2020 | -2.97 |